TY  - JOUR
AU  - Martín Sabroso, Cristina
AU  - Torres Suárez, Ana Isabel
AU  - Alonso-González, Mario
AU  - Fernández Carballido, Ana María
AU  - Fraguas Sánchez, Ana Isabel
PY  - 2021
DO  - 10.3390/pharmaceutics14010014
SN  - 1999-4923
UR  - https://hdl.handle.net/20.500.14352/92361
T2  - Pharmaceutics
AB  - In normal tissues, the expression of folate receptors is low and limited to cells that are important for embryonic development or for folate reabsorption. However, in several pathological conditions some cells, such as cancer cells and activated...
LA  - eng
M2  - 14
PB  - MPDI
KW  - Folic acid
KW  - Etarfolide
KW  - Mirvetuximab soravtansine;
KW  - Ovarian cancer
KW  - Rheumatoid arthritis
KW  - Targeted therapies
TI  - Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives
TY  - journal article
VL  - 14
ER  -